Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.
Minnesota health commissioner studies state support for cell and gene therapy innovation to treat rare diseases, reports findings, receives appropriated funding.